C 1027
Alternative Names: C 1027 chromophore; LidamycinLatest Information Update: 24 Apr 2007
Price :
$50 *
At a glance
- Originator Taiho Pharmaceutical
- Developer Chinese Academy of Medical Sciences; Taiho Pharmaceutical
- Class Amino acids; Cytostatic antibiotics
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 24 Nov 2000 Phase-II clinical trials for Cancer in China (Unknown route)
- 24 Nov 2000 Phase-II clinical trials for Cancer in Japan (Unknown route)
- 23 Feb 2000 Profile reviewed, but no significant changes made